Biocon Share Price Today | Stock Price & Biocon Share Screener

Track the current stock price of Biocon with an interactive chart. Analyse BIOCON share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Biocon stock quote in one place.

The quote of ₹323.50 sits between the 52-week low of ₹323.50 and the 52-week high of ₹440.70, and the latest session moved -2.06% from the previous close.

Screen Biocon company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BIOCON shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Kiran Mazumdar Shaw listed as chairperson or CEO, and it trades under ISIN INE376G01013.

Biocon Limited is India's largest fully-integrated biopharmaceutical company, focusing on biotechnology products and research services. Founded in 1978, Biocon specializes in treating diabetes, cancer, and autoimmune diseases. The company develops and commercializes novel biologics, biosimilars, complex small molecule APIs, and generic formulations for global markets. Biocon's product portfolio includes cardiology,...more

Classification

Identifiers and Leadership

Screen BIOCON balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹63,651, up from ₹58,797 in 2025.

Latest statistics put total assets at ₹63,651 and shareholder funds at ₹36,622, with a leverage ratio of 0.61.

Screen Biocon income statement and profit fundamentals. Analyze BIOCON quarterly results. Biocon reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹4,346 and net profit was ₹137, equal to earnings per unit of ₹0.87, at an operating margin of 18%.

In that period expenses were ₹3,502, interest cost ₹213 and tax ₹-9. The next period listed, 2026-Mar, shows revenue of ₹4,537 and net profit of ₹199.

Screen BIOCON cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1,994, and net cash flow was an outflow of ₹812.

Over the same period, investing activities used ₹1,883 and financing activities used ₹924.

See Biocon shareholding pattern with promoter, FII, and DII holdings. Check Biocon promoter holding and ownership changes for BIOCON on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jan, promoters held 44.91%, foreign institutions 7.14%, domestic institutions 24.16% and the public 10.23%, spread across 394,215 shareholders.

The shareholder count was 394,215 in 2026-Jan, compared with 386,593 in 2026-Mar.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Biocon. Biocon dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.14%, compared with ₹0.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹0.50 and ₹0.50 per unit.

See which indices include Biocon stock. Check BIOCON index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 23 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE200.

Get Biocon corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Biocon stock events that may affect BIOCON share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Extraordinary General Meeting dated December 31, 2026, with a record date of December 31, 2026.

It is followed by Annual General Meeting dated August 6, 2026 and Quarterly Result Announcement dated August 5, 2026.

Screen BIOCON competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen BIOCON latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 20, 2026.

The next most recent announcements are dated October 18, 2026 and October 16, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 25, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.